Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sigachi IndustriesBOM:543389 +1.97%75 Days Payable is 90.38 as of Mar. 2026, which is 139% above its 10-year median of 37.86. GuruFocus rates BOM:543389 with a GF Score™ of 75/100 and a GF Value™ of ₹48.18 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 926 Drug Manufacturers companies, Sigachi Industries ranks worse than 56.05% on this metric.
The historical rank and industry rank for Sigachi Industries's Days Payable or its related term are showing as below:
BOM:543389'
s Days Payable Range Over the Past 10 Years
Min: 23.61 Med: 37.86 Max: 80.34
Current: 80.34
During the past 8 years, Sigachi Industries's highest Days Payable was 80.34. The lowest was 23.61. And the median was 37.86.
BOM:543389's Days Payable is ranked worse than 56.05% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs BOM:543389: 80.34
Sigachi Industries's Days Payable
increased
from Mar. 2025 (63.84) to Mar. 2026 (90.38).
It may suggest that Sigachi Industriesdelayed paying its suppliers.
Sigachi Industries Days Payable Related Terms
Sigachi Industries Days Payable Historical Data
* Premium members only.
The historical data trend for Sigachi Industries's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sigachi Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigachi Industries Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sigachi Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where Sigachi Industries's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sigachi Industries's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sigachi Industries (BOM:543389) has a Days Payable of 90.38 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sigachi Industries and its competitors. This is 139% above median its historical median of 37.86. Over the past decade, Sigachi Industries' Days Payable has ranged from 23.61 to 80.34. According to the industry distribution chart, Sigachi Industries ranks #519 out of 926 companies in the Drug Manufacturers industry, placing it in the top 56%.
Is Sigachi Industries' Days Payable too high?
Sigachi Industries' current Days Payable of 90.38 is 139% above median its 10-year median of 37.86. Over the past 10 years, this metric has ranged from a low of 23.61 to a high of 80.34. The Drug Manufacturers industry median Days Payable is 90.22. Sigachi Industries' value of 90.38 is 0.2% above this industry median. Based on the distribution chart, Sigachi Industries ranks #519 out of 926 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sigachi Industries has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sigachi Industries' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sigachi Industries ranks #519 out of 926 companies for Days Payable. This places Sigachi Industries in the lower half of its industry. The industry median Days Payable is 90.22. Sigachi Industries' value of 90.38 is 0.2% above this benchmark. Historically, Sigachi Industries' own Days Payable has ranged from 23.61 to 80.34 over the past decade. While the company's 10-year median is 37.86 vs. the industry median of 90.22, Sigachi Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigachi Industries's current Days Payable of 90.38 is 0.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sigachi Industries and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigachi Industries's current Days Payable is 90.38, which is 139% above median its own 10-year median of 37.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigachi Industries stock overvalued right now?
Based on GuruFocus' analysis, Sigachi Industries (BOM:543389) is currently considered Possible Value Trap. The stock's GF Value™ is ₹48.18, compared to a current price of ₹25.92 — trading 46.2% below its estimated fair value. The current Days Payable is 90.38, which is 139% above median its 10-year median of 37.86 and 0.2% above the Drug Manufacturers industry median of 90.22. Sigachi Industries' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sigachi Industries (BOM:543389), the current Days Payable is 90.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigachi Industries (BOM:543389) Overvalued in 2026?
Based on GuruFocus' analysis, Sigachi Industries stock appears to be undervalued.
The current stock price of ₹25.92 is trading 46.2% below its estimated GF Value™ of ₹48.18.
GuruFocus considers Sigachi Industries to be Possible Value Trap.
Key valuation signals for BOM:543389:
Days Payable: 90.38 (139% above median its 10-year median of 37.86)
GF Value™: ₹48.18 vs. price of ₹25.92 (46.2% below fair value)
Industry Position: 0.2% above the Drug Manufacturers median (#519 of 926)
No single metric tells the full story. See the BOM:543389 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigachi Industries Ltd is engaged in the manufacturing of Microcrystalline Cellulose (MCC), which is widely used as an excipient for finished dosages in the pharmaceutical industry. The Company is mainly pursuing only one activity which is manufacturing and selling of MCC. The company manufactures MCC of various grades ranging from 15 microns to 250 microns and the crucial grades of MCC manufactured and marketed by the company are branded as HiCel and AceCel.
75GF Score
Get the complete analysis for BOM:543389
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543389 has been successfully added to your 
